EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Adverse drug reactions – answers 239<br />
H<br />
-Adrenoceptor receptor blockade by a -adrenoceptor antagonist<br />
( blocker) can cause symptoms of cold peripheries and impotence,<br />
which may affect compliance. All -adrenoceptor antagonists are<br />
contra<strong>in</strong>dicated <strong>in</strong> patients with asthma as a result of the risk of<br />
airway obstruction.<br />
Blockers have a role <strong>in</strong> many aspects of cardiovascular disease, <strong>in</strong>clud<strong>in</strong>g<br />
treatment of hypertension, ang<strong>in</strong>a and arrhythmias.<br />
Blockers can also be used under specialist control for the treatment of<br />
heart failure.<br />
94 Adverse drug reactions<br />
Answers: N C L A I<br />
N<br />
C<br />
L<br />
A 21-year-old woman treated with medication for migra<strong>in</strong>e develops<br />
acute dystonia.<br />
Acute dystonic reactions (<strong>in</strong>clud<strong>in</strong>g oculogyric crises) are recognized<br />
adverse effects of metoclopramide. These reactions are more common<br />
<strong>in</strong> the young.<br />
Metoclopramide is a dopam<strong>in</strong>e receptor antagonist that acts centrally on<br />
the chemoreceptor trigger zone (CTZ). It also acts directly on the gastro<strong>in</strong>test<strong>in</strong>al<br />
tract to prevent vomit<strong>in</strong>g by enhanc<strong>in</strong>g gastric empty<strong>in</strong>g.<br />
A 35-year-old man on treatment for depression compla<strong>in</strong>s of a severe<br />
throbb<strong>in</strong>g headache soon after his even<strong>in</strong>g meal. Blood pressure is<br />
markedly raised.<br />
This is a presentation of a ‘cheese’ reaction. Many foods, e.g. cheese and<br />
yeast products, conta<strong>in</strong> tyram<strong>in</strong>e which is normally metabolized by<br />
monoam<strong>in</strong>e oxidases <strong>in</strong> the gut wall and liver. However, phenelz<strong>in</strong>e is a<br />
monoam<strong>in</strong>e oxidase <strong>in</strong>hibitor and thus allows a larger amount of<br />
tyram<strong>in</strong>e to reach the systemic circulation. Tyram<strong>in</strong>e is a sympathomimetic<br />
and, therefore, the potentiation of this action by monoam<strong>in</strong>e<br />
oxidase <strong>in</strong>hibition can give rise to an acute hypertensive crisis. The<br />
treatment of choice is <strong>in</strong>travenous phentolam<strong>in</strong>e (-adrenoceptor<br />
antagonist).<br />
Reversible monoam<strong>in</strong>e oxidases (reversibly <strong>in</strong>hibit monoam<strong>in</strong>e oxidase<br />
type A) are available, e.g. meclobemide, which are claimed to cause less<br />
potentiation of the tyram<strong>in</strong>e effect. However, patients should be<br />
counselled very carefully regard<strong>in</strong>g the avoidance of tyram<strong>in</strong>e-rich food<br />
when prescribed either class of drug.<br />
A 34-year-old woman suffers from haemorrhagic cystitis after<br />
receiv<strong>in</strong>g medication for systemic lupus erythematosus (SLE).<br />
Cyclophosphamide is a potent cytotoxic drug that can be used to <strong>in</strong>duce<br />
remission of severe flares of SLE.